The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-I

Journal of Endocrinological Investigation

Volumn 19, Issue 9, 1996, Pages 620-623

  Prummel, M F ^a,b   Wiersinga, W M ^a   Oosting, H ^a   Endert, E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Catabolism; Corticosteroids; Growth hormone; Insulin like growth factor 1

Indexed keywords

GROWTH HORMONE; PREDNISONE; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EUTHYROIDISM; EYE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; IRRADIATION; MALE; ORAL DRUG ADMINISTRATION; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

EID: 0029857026     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349028     Document Type: Article

References (19)

1. Ross R.J.M., Miell J.P., Luchanan C.R. Avoiding autocannibalism. Consider growth hormone and insulin-like growth factor 1. Br. Med. J. 303: 11477, 1991.
2. Bondy C.A. Clinical uses of Insulin-like Growth Factor 1. Ann. Intern. Med. 120: 5937, 1994.
3. Clemmons D.R., Underwood L.E. Uses of human Insulin-like Growth Factor-1 in clinical conditions. J. Clin. Endocrinol. Metab. 79: 47, 1994.
4. Fine R.N. Corticosteroids and growth. Kidney Int. 44 (Suppl 43): S-59.
5. Veldhuis J.D., Lizarralde G., Iranmanesh A. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J. Clin. Endocrinol. Metab. 74: 967, 1992.
6. Miell J.P., Corder R., Pralong F.P., Gaillard R.C. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma Insulin-like Growth Factor-1 concentrations in normal male volunteers. J. Clin. Endocrinol. Metab. 72: 6757, 1991.
7. Magiakou M.A., Mastorakos G., Gomez M.T., Rose S.R., Chrousos G.P. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J. Clin. Endocrinol. Metab. 78: 131, 1994.
8. Gourmelen M., Girard F., Binoux M. Serum Somatomedin/Insulin-Like Growth Factor (IGF) and IGF Carrier Levels in Patients with Cushing's Syndrome or receiving Glucocorticoid Therapy. J. Clin. Endocrinol. Metab. 54: 885, 1982.
9. Reid I.R., Gluckman P.D., Ibbertson H.K. Insulin-like Growth factor 1 and bone turnover in glucocorticoid-treated and control subjects. Clin. Endocrinol. (Oxf.) 30: 347, 1989.
10. Furlanetto R.W., Underwood L.E., Van Wyk J.J., D'Ercole A.J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J. Clin. Invest. 60: 648, 1977.
11. Prummel M.F., Mourits M.Ph., Blank L., Berghout A., Koornneef L., Wiersinga W.M. Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 342: 949, 1993.
12. Giustina A., Doga M., Bodini C., Girelli A., Legati F., Bossoni S., Romanelli G. Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. Acta Endocrinol. (Copenh.) 122: 206, 1990.
13. Sanchez C.P., Goodman W.G., Brandli D., Goldenhersh M., Murray C., Carlton E., Hahn T., Salusky I.B. Skeletal response to recombinant human Growth Hormone (rhGH) in children treated with long-term corticosteroids. J. Bone Miner. Res. 10: 2, 1995.
14. Lukert B.P, Raisz L.G. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann. Intern. Med. 112: 352, 1990.
15. Horber F.F., Haymond M.W. Human Growth Hormone Prevents the Protein Catabolic Side Effects of Prednisone in Humans. J. Clin. Invest. 86: 265, 1990.
16. Giustina A., Bussi A.R., Jacobello C., Wehrenberg W.B. Effects of recombinant Growth Hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 80: 122, 1995.
17. Zapf J. Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132: 645, 1995.
18. Unterman T.G., Phillips L.S. Glucocorticoid Effects on Somatomedins and Somatomedin Inhibitors. J. Clin. Endocrinol. Metab. 61: 618, 1985.
19. Mauras N., Beaufrere B. Recombinant human Insulin-like Growth factor-1 enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J. Clin. Endocrinol. Metab. 80: 869, 1995.